Monthly News Roundup - August 2020

Novartis’ Kesimpta Cleared to Treat Multiple Sclerosis The U.S. Food and Drug Administration (FDA) has approved Kesimpta (ofatumumab), a CD20-directed cytolytic IgG1 antibody used to treat relapsing forms of multiple sclerosis (MS) in adults,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news